Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda R Moore

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2020
Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal MelanomaTyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo, et al.
Science Advances|April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancerDan Li, Yu Zhan, Naitao Wang, et al.
Nature Genetics|June 11, 2026
Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy responseAmanda R Moore, Brian Biehs, Noelyn Kljavin, et al.
Nature|October 11, 2019
Spliceosomal disruption of the non-canonical BAF complex in cancerDaichi Inoue, Guo-Liang Chew, Bo Liu, et al.
Nature|May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanomaIvana Yen, Frances Shanahan, Jeeyun Lee, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2020
Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal MelanomaTyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo, et al.
Science Advances|April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancerDan Li, Yu Zhan, Naitao Wang, et al.
Nature Genetics|June 11, 2026
Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy responseAmanda R Moore, Brian Biehs, Noelyn Kljavin, et al.
Nature|October 11, 2019
Spliceosomal disruption of the non-canonical BAF complex in cancerDaichi Inoue, Guo-Liang Chew, Bo Liu, et al.
Nature|May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanomaIvana Yen, Frances Shanahan, Jeeyun Lee, et al.
Pageof 2